Author:
Eugenia Cornide-Petronio Maria,Mendes-Braz Mariana,B. Jiménez-Castro Mónica,Gracia-Sancho Jordi,Peralta Carmen
Reference87 articles.
1. Baumann AJ, Wheeler DS, James M, Turner R, Siegel A, Navarro VJ. Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation. Journal of Pain and Symptom Management. 2015;50(6):882-886.e2. DOI: 10.1016/j.jpainsymman.2015.07.014
2. Knaak J, McVey M, Bazerbachi F, Goldaracena N, Spetzler V, Selzner N, et al. Liver transplantation in patients with end-stage liver disease requiring intensive care unit admission and intubation. Liver Transplantation. 2015;21(6):761-767. DOI: 10.1002/lt.24115
3. Jimenez-Castro M, Elias-Miró M, Peralta C. Expanding the donor pool in liver transplantation: Influence of ischemia-reperfusion. In: Saidi RF, editor. Organ Donation and Organ Donors: Issues. New York: NOVA Science Publishers, Inc; 2013. p. 41-82
4. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transplantation. 2003;9(7):651-663. DOI: 10.1053/jlts.2003.50105
5. Gallegos-Orozco JF, Vargas HE, Rakela J. Virologically compromised donor grafts in liver transplantation. Journal of Hepatology. 2004;41(4):512-521. DOI: 10.1016/j.jhep.2004.08.003